{"data":{"type":"company_profile","id":180147,"entity_id":"wefunder:company:180147","attributes":{"canonical_url":"https://wefunder.com/sunstone.health","generated_at":"2026-06-05T02:45:42Z","updated_at":"2026-06-04T21:34:50Z","entity_ids":{"company":"wefunder:company:180147","slug":"wefunder:company_slug:sunstone.health"},"profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-05T02:45:42Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-04T21:34:50Z","as_of":"2026-06-05T02:45:42Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-04T21:34:50Z","as_of":"2026-06-05T02:45:42Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2026-05-01T05:06:56Z","as_of":"2026-06-05T02:45:42Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2026-05-01T05:06:56Z","as_of":"2026-06-05T02:45:42Z","confidence":"medium"}}},"company":{"id":180147,"entity_id":"wefunder:company:180147","slug":"sunstone.health","name":"Sunstone Health","tagline":"AI-powered precision health platform for kids with genetic diseases. ","story":"AI to Power the Healthcare Revolution1 in 31 kids has autism. In today's system, the path to a genetic answer takes years. With Sunstone's AI, it's 12 weeks.$1M left to close our Series A. $8.5M valuation set by Saturn Partners. 6.5M+ lives in our pipeline. Pilots live now.What we do.We end the diagnostic odyssey — years of wrong specialists, wrong tests, and wrong treatment. It's the single biggest cost sink in genetic disease.How we do it.We sell self-insured employers a benefit for their employees' families.Our AI finds the kids in the claims data. Broad Clinical Labs sequences their genome. Our doctors deliver a plan to their doctor.12 weeks, end to end. Not 7 years.Why autism is broken.1 in 31 kids. ABA therapy costs employers $40K–$60K per child per year.Autism is deeply genetic. About 30% of cases have an identifiable genetic cause today, and that number grows every year as the science improves. But fewer than 20% of kids with autism ever get a genetic test — even though every major pediatric board recommends it.So therapy gets built on guesswork. A child gets the wrong care for years. One undiagnosed case can cost $3.1M over a lifetime.The kids are in the data. Nobody is looking.Christopher. Age 7.Before Sunstone: 40 hours of therapy a week. No plan. No genetic test. $58,400/year.After Sunstone: Fragile X found. Therapy rebuilt around it. Real progress in 6 months. $21,200/year.64% less money. A child with a plan. A family with answers.How we make money.$10,000 per case we solve. Flat fee. Paid only after we deliver the doctor-to-doctor care plan.One case that breaches a $250K stop-loss = 25× ROI. And the employee gets something priceless: real answers for their kid.60%+ gross margin at scale.Autism today. Every genetic disease tomorrow.We start with autism — the pain is real, the market is big, the genetics are clear.Then: pediatric epilepsy. Rare disease. Adult genetic conditions. The identification layer we build for autism becomes the layer for every genetic disease in employer health plans.Where we are.6.5M+ lives in active pipelineFortune 50 telecom — NDA signed, principal benefits buyerNational grocery chain — pilot explorationCare management platform — 200K lives, contract finalizationBroad Clinical Labs — signed lab deal with the institution behind the Human Genome ProjectAdvisors from Mass General Brigham, Medco, Illumina, Proteus, Alva10We have contracts on the table.Why I built this.I'm Joshua. Biomedical engineer, Harvard-trained. My son has PFAPA — a rare autoimmune condition with no treatment.I know what the system does to families who don't fit its script. I lived it.So I built what we all needed.The round. Raising$1M to closePre-money$8.5M — Saturn Partners, 1× prefRevenuePay-for-results — only on deliveryUse of fundsClose pilots, scale ops, launch 1/1/27Why community.We could have closed this with institutions. We chose you.Because the people who understand why Sunstone matters are the ones who've lived it. Parents. Clinicians. Benefits pros. Anyone who's watched the system fail a kid.We want you in. Not for the check. For the army.Startup investing is risky. You may lose your entire investment. See Form C on Wefunder for full terms.","location":"Boston, MA","website":"https://www.sunstonehealth.com","total_amount_raised":1658634,"total_investors":886,"is_funded":true,"is_active":true,"related_urls":["https://wefunder.com/sunstone.health","https://www.sunstonehealth.com"]},"media":{"share_image_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/180147/xxl_avatar.jpg","logo_url":"https://uploads.wefunder.com/uploads/company/logo/180147/large_avatar.jpg","header_media_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/180147/standard_avatar.jpg","cover_photo_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/180147/standard_avatar.jpg","pitch_deck_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MTcyNzI0NSwicHVyIjoiYmxvYl9pZCJ9fQ==--6645caa90907ff2d04b2ce98dca1d7970a60f7f4/Sunstone%20Series%20A%20Public%20Deck%202026%20(1).pdf","pitch_deck_filename":"Sunstone Series A Public Deck 2026 (1).pdf"},"links":{"company_url":"https://www.sunstonehealth.com","linkedin_url":"https://linkedin.com/company/sunstonehealth","facebook_url":"https://facebook.com/sunstonehealth","instagram_url":"https://instagram.com/sunstonehealthofficial","youtube_url":"https://youtube.com/Sunstone_Health"},"highlights":[{"id":62781,"name":"venture_backed","url":"venturebacked","presentable_name":"VC-Backed","description":"Raised $250K or more from a venture firm","image_url":"https://uploads.wefunder.com/2021/profile-highlights-check.svg"},{"id":75537,"name":"repeat_founder","url":"repeatfounder","presentable_name":"Repeat Founder","description":"Started a prior company with $2M+ in funding or revenue","image_url":"https://uploads.wefunder.com/2021/profile-highlights-replay.svg"}],"quick_facts":[{"index":1,"claim_id":"claim-fact-1","value":"Reduces 7-year diagnostic odyssey into a 12-week precision care solution"},{"index":2,"claim_id":"claim-fact-2","value":"Proven with \u0026gt;400 families, 90% opt-in, active with major US health plans"},{"index":3,"claim_id":"claim-fact-3","value":"AI powered pattern recognition finds kids with genetic diseases in claims data"},{"index":4,"claim_id":"claim-fact-4","value":"First-to-market, trade-secret and method-patented model built for scale"},{"index":5,"claim_id":"claim-fact-5","value":"Partnered with NVIDIA Inception Program, Creative Destruction Lab Computational Health Cohort 2024"},{"index":6,"claim_id":"claim-fact-6","value":"Backed by team of Advisors and Investors with Billions in successful exits"}],"team":[{"id":6593362,"entity_id":"wefunder:company_role:6593362","user_entity_id":"wefunder:user:4995598","role":"founder","name":"Joshua Resnikoff","title":"CEO + Cofounder","bio":"Biomedical engineer and entrepreneur in translational science and consumer products. 14 patents, work showcased in national news, and has scaled businesses to \u0026gt;3000x ROI. Focused on using business as a force for good.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/6593362/square_avatar.jpg?1777060124","profile_url":"https://wefunder.com/joshua.resnikoff.2","related_urls":["https://wefunder.com/joshua.resnikoff.2"]},{"id":5671536,"entity_id":"wefunder:company_role:5671536","role":"employee","name":"Calum MacRae","title":"Head of Innovation","bio":"30+ years as a global leader in cardio, genomics, and AI, working extensively with Apple, Meta, Samsung and Google. Awarded AHA $75M grant to found \"One Brave Idea\", and runs Apple's Movement Study at BWH Hospital.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5671536/square_blob.jpg?1776961152","linkedin_url":"https://linkedin.com/in/calummacrae/","related_urls":[]},{"id":5671543,"entity_id":"wefunder:company_role:5671543","user_entity_id":"wefunder:user:4767579","role":"employee","name":"Sofia Giraldo","title":"Director of Operations","bio":"Previously led Customer Success at Promedan IPS, one of the largest hospitals in Medellin, Colombia. Her efforts contributed to improved operational efficiency and patient satisfaction, aligning with her passion for transforming healthcare delivery.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5671543/square_blob.jpg?1776961152","profile_url":"https://wefunder.com/sofia.giraldo","linkedin_url":"https://linkedin.com/in/sofia-giraldo-quintero-8109b0178/","related_urls":["https://wefunder.com/sofia.giraldo"]},{"id":6558311,"entity_id":"wefunder:company_role:6558311","role":"employee","name":"Paterson Anaccius","title":"Lead Full Stack Developer","bio":"Over a decade of experience scaling complex platforms across healthcare, telecom, and SaaS, including contributing to Truepill’s growth and building large-scale automation systems at Bell Canada.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/6558311/square_avatar.jpg?1776961152","linkedin_url":"https://linkedin.com/in/paterson-a-40b076134/","related_urls":[]},{"id":6558313,"entity_id":"wefunder:company_role:6558313","user_entity_id":"wefunder:user:4992331","role":"employee","name":"Jonathan Calixte","title":"Full Stack Developer","bio":"Deep experience building and scaling high-throughput platforms across gaming, fintech, and Web3","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/6558313/square_avatar.jpg?1776961152","profile_url":"https://wefunder.com/jonathan.calixte","linkedin_url":"https://linkedin.com/in/jonathan-junior-calixte/","related_urls":["https://wefunder.com/jonathan.calixte"]},{"id":6558314,"entity_id":"wefunder:company_role:6558314","role":"employee","name":"Cameron Pearson","title":"Automation Architect","bio":"Deep expertise in building scalable data, product, and automation systems across healthtech and complex B2B environments","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/6558314/square_avatar.jpg?1776961152","linkedin_url":"https://linkedin.com/in/vdm-ri/","related_urls":[]},{"id":5671533,"entity_id":"wefunder:company_role:5671533","user_entity_id":"wefunder:user:4752457","role":"founder","name":"Martin Grasso","title":"CCO + Cofounder","bio":"Over three decades of experience in venture finance, development and asset management of technology and healthcare enterprises.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5671533/square_blob.jpg?1776961152","profile_url":"https://wefunder.com/martin.grasso","linkedin_url":"https://linkedin.com/in/martin-j-g-6698786/","related_urls":["https://wefunder.com/martin.grasso"]},{"id":5672503,"entity_id":"wefunder:company_role:5672503","role":"employee","name":"Dr. Javier Romero","title":"Lead Medical Advisor","bio":"Director of Neuroradiology at MGH, built and published on AI tech for multiplexed image processing and patient triage. 20+ years leading international efforts in neurology and scientific leadership.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5672503/square_blob.jpg?1776961152","related_urls":[]}],"featured_investors":[{"id":12748,"entity_id":"wefunder:company_investor_profile:12748","investor_profile_id":3878463,"investor_profile_entity_id":"wefunder:investor_profile:3878463","subject_entity_id":"wefunder:notable_investor:12685","name":"Kingscrowd Capital","role_title":"Senior Investor","bio":"Kingscrowd Capital is the first Data-Driven Fund in the Online Private Market.","avatar_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MTQ2OTAsInB1ciI6ImJsb2JfaWQifX0=--dacedb40a396840ff4e386dccd425cea223bd1c0/filename","profile_url":"https://wefunder.com/kingscrowd.capital.3","endorsement_quote":"TMA is tackling a large and painful problem with a differentiated solution, strong early validation, and a capable team. At its current valuation, we view this as a compelling entry point for KC Capital. We are excited to join TMA Precision Health as it works to become a leader in AI-enabled precision medicine for genetic disease patients.","endorsement_name":"Teddy Lyons","investment_total":10000,"investment_info":"Invested $10,000 this round","is_lead_investor":false,"memo_paid_for_by_company":false,"related_urls":["https://wefunder.com/kingscrowd.capital.3"]},{"id":11526,"entity_id":"wefunder:company_investor_profile:11526","investor_profile_id":4243743,"investor_profile_entity_id":"wefunder:investor_profile:4243743","subject_entity_id":"wefunder:notable_investor:15276","name":"Saturn Investment Partners","role_title":"Founder and Managing Partner","bio":"Saturn Partners has a seasoned, cohesive investment team with specialized expertise in managing, advising and investing in early-stage companies. Each of our portfolio companies benefits from the attention and expertise of our entire team, not just one partner. We all share one goal: creating substantial value for investors while helping smart entrepreneurs solve some of the world’s biggest challenges.","avatar_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6NDQzNTEzLCJwdXIiOiJibG9iX2lkIn19--b305bc6608bd8de0aca1ce9b5466a2c7bfdbbe37/filename","profile_url":"https://wefunder.com/saturn.investment.partners","endorsement_quote":"Saturn is thrilled to participate in this Series A round because we firmly believe the future of medicine is in the use of genomics in bringing precision medicine to drive real value for health plans and into the healthcare ecosystem at large.","endorsement_name":"Jeff McCormick","investment_total":2000000,"investment_info":"Invested $2,000,000 this round","is_lead_investor":false,"memo_paid_for_by_company":false,"related_urls":["https://wefunder.com/saturn.investment.partners"]},{"id":11527,"entity_id":"wefunder:company_investor_profile:11527","investor_profile_id":4243738,"investor_profile_entity_id":"wefunder:investor_profile:4243738","subject_entity_id":"wefunder:notable_investor:15275","name":"Henry Albrecht","role_title":"","bio":"Henry Albrecht is the founder and former CEO of Limeade, an employee well-being and experience SaaS company he started in 2006 and grew from a basement idea into a $60M-revenue public company, ultimately acquired by WebMD. At Limeade, he helped define the future of work by building the #1 Best Company to Work For in Washington and earning recognition such as EY Entrepreneur of the Year, and he now serves as a board director, advisor, and mentor to disruptive companies and their CEOs.","avatar_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6OTY4NTMxLCJwdXIiOiJibG9iX2lkIn19--6ea6072a0856b507402d5f41ee5938d0b76b76cc/filename","profile_url":"https://wefunder.com/henry.albrecht","endorsement_quote":"I invested in TMA because Josh and his team combine a rare, human-centered mission with a precision-health platform that’s designed to scale. They’re solving a problem that deeply affects families today while opening a massive opportunity to transform how payers care for complex patients. That combination of purpose and market readiness is exactly what I look for.","endorsement_name":"","investment_total":100000,"investment_info":"Invested $100,000 this round","is_lead_investor":false,"memo_paid_for_by_company":false,"related_urls":["https://wefunder.com/henry.albrecht"]},{"id":12775,"entity_id":"wefunder:company_investor_profile:12775","investor_profile_id":4459164,"investor_profile_entity_id":"wefunder:investor_profile:4459164","subject_entity_id":"wefunder:notable_investor:16609","name":"Alan Sakowitz","role_title":"","bio":"Alan Sakowitz is the CEO of Pointe Development Company, a seasoned real-estate developer, attorney, author, and early-stage investor renowned for his disciplined approach to value creation and unwavering commitment to ethical leadership. With more than three decades of experience in real estate development, law, financing, and asset management, Alan has successfully led complex commercial and residential projects across multiple markets. A graduate of the University of Miami School of Law, he holds both a JD and an LLM in federal taxation. Alan is also the author of Miles Away… Worlds Apart, a widely recognized book that details his pivotal role in exposing one of Florida’s largest Ponzi schemes. Today, as an active angel investor, Alan brings founders a distinctive blend of legal expertise, operational insight, and principled, long-term support—making him a trusted partner for mission-driven companies.","avatar_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6OTk1MTk4LCJwdXIiOiJibG9iX2lkIn19--7e2898ab3d271979789b1c52e183e1bc3b62618a/filename","profile_url":"https://wefunder.com/alan.sakowitz","endorsement_quote":"Upon speaking with Joshua Resnikoff, we were impressed by his clear communication, ability to build and manage a seamless process, and strong leadership. These personal impressions led us to invest. TMA Precision Health’s model is designed to create a strong alignment of interests: a win-win-win-win for insurers/employers, patients, families, and TMA itself. The structure—where TMA is paid only upon successfully helping the insured—turns the program into real savings rather than an added expense for payers, which could significantly reduce sales friction and incentivize referrals. The use of AI to enable a lean team to deliver high-level service at low cost, with apparent scalability and minimal marginal cost per case, struck us as compelling. Most importantly, the possibility of identifying life-changing medical solutions in weeks rather than years will provide patients and families with both cost savings and genuine peace of mind and hope. It’s rare to find a company that is both commercially powerful and profoundly impactful for society. We believe TMA does both and, therefore, we are proud to be a lead investor in this round and look forward to TMA’s continued growth and success.","endorsement_name":"","investment_total":100000,"investment_info":"Invested $100,000 this round","is_lead_investor":false,"memo_paid_for_by_company":false,"related_urls":["https://wefunder.com/alan.sakowitz"]}],"investor_memos":[],"tab_counts":{"posts":3,"ask_questions":44,"featured_investors":4,"faq_entries":5},"active_fundraises":[{"id":140199,"entity_id":"wefunder:fundraise:140199","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"ttw","security_type":"","currency":"USD","testing_the_waters":true,"min_purchase":100,"max_purchase":9,"funding_target":5000000.0,"minimum_target":"50000.0","maximum_target":"5000000.0"},{"id":140198,"entity_id":"wefunder:fundraise:140198","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"equity","security_type":"equity","currency":"USD","testing_the_waters":false,"min_purchase":100,"max_purchase":9,"funding_target":50000.0,"minimum_target":"50000.0","maximum_target":"5000000.0","funding_started_at":"2025-07-16T22:23:50Z","funding_closed_at":"2026-05-01T03:59:59Z","auto_close_at":"2026-05-01T03:59:59Z"}],"latest_fundraise":{"id":140199,"entity_id":"wefunder:fundraise:140199","state":"successful","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":false,"funding_started_at":null,"funding_closed_at":null,"terms":{"eb":null,"nb":"$8.5M","txt":"pre-money valuation"}},"recent_posts":[{"id":300892,"entity_id":"wefunder:feed_item:300892","type":"FeedItem::Update","visibility":"public","title":"Heads Down, Moving Forward.","preview":"Our community round is open through April 30, 2026 — 15 days leftHi Sunstone community —It's been a minute since you've heard from me — that's because we've been heads down, deep in the work. This is the busy season for us — we're in active conversations, we're at conferences, and we're building every day.Wanted to pop in and just say — thank you. You've helped us raise $3,936,676 in our Series A, and that means everything to this team.Quick reminder: our round closes April 30th. If you've be...","published_at":"2026-04-15T17:14:51Z","author_name":"Joshua Resnikoff","url":"/feed/300892","canonical_url":"https://wefunder.com/feed/300892"},{"id":263287,"entity_id":"wefunder:feed_item:263287","type":"FeedItem::Update","visibility":"public","title":"Sunstone in Reuters!","preview":"This week, Reuters ran a piece on Sunstone and on the problem we are built to fix: families with genetic disease get stuck in a system that moves slowly, pays late, and often leaves parents doing the coordination work themselves.What I like about this article is that it puts a spotlight on the real issue, incentives. Most plans are built around short time horizons, so early action is deprioritized even when it is the right clinical move and the smart economic move. When a child is waiting for...","published_at":"2026-02-20T16:24:48Z","author_name":"Joshua Resnikoff","url":"/feed/263287","canonical_url":"https://wefunder.com/feed/263287"},{"id":262889,"entity_id":"wefunder:feed_item:262889","type":"FeedItem::Update","visibility":"public","title":"March 4 - Community Update","preview":"We moved the community session to March 4 at noon ET.I want to use that time to walk through what has actually changed since we moved from TMA to Sunstone, what our commercial pipeline looks like right now, and how we are positioning ourselves in the stop-loss and employer markets.This is a straight update for the people who have backed us and the people thinking seriously about backing us.If you want to understand how we are thinking about the next stage and what the actual strategy looks li...","published_at":"2026-02-19T22:24:25Z","author_name":"Lauren Damon","url":"/feed/262889","canonical_url":"https://wefunder.com/feed/262889"}],"q_and_a":[{"id":315039,"entity_id":"wefunder:comment:315039","question":"Will this investment qualify for QSBS status allowing investors to avoid cap gains on up to $15M of sale proceeds? Thx.","author_name":"Mike Mathioudakis","votes":7,"created_at":"2025-09-16T18:59:43Z","canonical_url":"https://wefunder.com/sunstone.health#question-315039","answers":[{"id":315042,"entity_id":"wefunder:comment:315042","answer":"Hi Mike, Thanks for your question. Disclaimer: WE CANNOT PROVIDE YOU WITH TAX ADVICE AND HAVE NOT CONSULTED WITH A TAX PROFESSIONAL ON YOUR SPECIFIC QUESTION. However, given the fact that a professional lead investor has set the price of these shares at a level that exceeds the de minimis threshold standard for qualifying for QSBS or Rule 83-b treatment, and other professional investors have purchased our preferred shares at this level, it seems unlikely that these shares will qualify for QSBS treatment. Thanks for your interest in TMA!","author_name":"Martin Grasso","votes":0,"created_at":"2025-09-16T19:40:01Z"}]},{"id":310095,"entity_id":"wefunder:comment:310095","question":"Joshua, A brilliant video briefly telling your personal story that demonstrates you and your teams specific abilities to deliver. I am a huge believer in, and personally benefited from precision medicine to drastically reduce diagnosis from years to weeks. From your presentation,\"We’re Focused on Serving Self-Funded Employers Covering healthcare costs directly for 65% of the insured U.S. population, employers that offer self-funded insurance plans have a dedicated interest in their members’ health and satisfaction, and a financial responsibility to contain costs — and they can move fast when a solution works. With 90% patient opt-in and a pay-for-results model, TMA offers them a no-risk turnkey solution to improve care and decrease spend while improving member outcomes.\" The 23andMe DNA patient database was a risk of being sold to the highest bidder when in bankruptcy court. However, I believe you have an exceptional plan for success. The 90% patient opt-in rate might drop if there is fear of being DNA identified as a costly risk. How do you encourage a, \"With 90% patient opt-in and a pay-for-results model\" to prevent insurance companies from refusing to renew patient insurance policies? Regards, Allen","author_name":"Allen Barth","votes":7,"created_at":"2025-06-23T23:18:27Z","canonical_url":"https://wefunder.com/sunstone.health#question-310095","answers":[{"id":310124,"entity_id":"wefunder:comment:310124","answer":"Great question Allen, and thanks so much for your interest! Your question strikes right to the core of GINA, which is federal law that prohibits discrimination based on genetic information in health coverage and employment. Because we take patient data security very seriously, we go a step further by engaging directly with the patient for consent, and never sharing their information back with the insurer. The net is that the patients own their personal data and we provide them the \"right to be forgotten\"; they have full control over permissions to who can - and can not - access their data. As parents and patients ourselves, its an area we are extremely keen about protecting patient privacy on. Happy to go deeper anytime, and thanks for your support! Josh","author_name":"Joshua Resnikoff","votes":2,"created_at":"2025-06-24T13:06:20Z"}]},{"id":315467,"entity_id":"wefunder:comment:315467","question":"Very interesting concept. I would like to invest 10k. Can you confirm the price per share and the evaluation that I would be investing at. Are these preferred shares. Will I be receiving the 8% dividend. Thanks","author_name":"Yaakov Hersh","votes":6,"created_at":"2025-09-22T16:58:22Z","canonical_url":"https://wefunder.com/sunstone.health#question-315467","answers":[{"id":315468,"entity_id":"wefunder:comment:315468","answer":"Hello Yaakov, Thanks for your interest in TMA! The share price set by the lead investor is $.90342. These are for 1x preferred shares that accrue an 8% dividend that will be paid at the discretion of the board. We would love to have you on board before the round closes! Kind regards, Marty Grasso","author_name":"Martin Grasso","votes":1,"created_at":"2025-09-22T17:07:52Z"}]},{"id":312956,"entity_id":"wefunder:comment:312956","question":"The link I was looking for is to the webinar from Wednesday, August 6th at 1pm PST with Joshua Resnikoff and Travis Lacey, the CEO of Simplify Genomics","author_name":"Mark Williams","votes":6,"created_at":"2025-08-11T17:22:58Z","canonical_url":"https://wefunder.com/sunstone.health#question-312956","answers":[{"id":312958,"entity_id":"wefunder:comment:312958","answer":"No worries Mark, thanks for asking! I will be sending out an update as well, but here is the link and the passcode: https://us06web.zoom.us/rec/share/bk2VF_vNAtNle5LTQMIWxnL6ZEnYk-4yes7gJ9IzbHv8FRvTOl3F-fc9jYDV9Hp6.2sEAttnz_ZR0b5jm Passcode: V%2Pz2FM","author_name":"Joshua Resnikoff","votes":0,"created_at":"2025-08-11T17:27:26Z"}]},{"id":312946,"entity_id":"wefunder:comment:312946","question":"Can you please provide a link to the investor and commercial update presentation? I just saw this today.","author_name":"Mark Williams","votes":6,"created_at":"2025-08-11T16:21:55Z","canonical_url":"https://wefunder.com/sunstone.health#question-312946","answers":[{"id":312954,"entity_id":"wefunder:comment:312954","answer":"Hi Mark, Many thanks for your interest! If you scroll down on our offering page (https://wefunder.com/tmaprecisionhealth/), you will find all of the sections that you are looking for (Overview, Details, Updates, What People Say and Ask a Question) as live links to each of those categories. Please let me know if we can answer any additional questions that you may have as they arise. Kind regards, Marty Grasso","author_name":"Martin Grasso","votes":0,"created_at":"2025-08-11T17:14:39Z"}]},{"id":312718,"entity_id":"wefunder:comment:312718","question":"I asked questions back in June. Now 2 months passed. How does the numbers you mentioned below back in June look like now? \"We are currently pre-revenue, but have contracts that represent ~250,000 lives, and have a $2.3M revenue horizon for 2025.\" Also, if I invest today, when will this funding cycle approximately close? In other words, how soon will the shares in this round be allocated to investors?","author_name":"Yubing Sun","votes":6,"created_at":"2025-08-08T01:22:27Z","canonical_url":"https://wefunder.com/sunstone.health#question-312718","answers":[{"id":312755,"entity_id":"wefunder:comment:312755","answer":"Hello Yubing. Thank you for the outreach. We are still on track for the contractual revenue projected, and our pipeline grows larger every week. We expect to reach our fundraising threshold for a first closing ($3million) by the end of the month of August, given that we are only ~$55K short of that and raising new capital at a good clip every day. We will then have the first closing and allocate investor shares concurrently. I hope this answers your questions. Thank for your interest in TMA Precision Health!","author_name":"Martin Grasso","votes":0,"created_at":"2025-08-08T14:46:47Z"}]},{"id":311594,"entity_id":"wefunder:comment:311594","question":"What is the current price per share","author_name":"John Reid","votes":6,"created_at":"2025-07-19T20:20:06Z","canonical_url":"https://wefunder.com/sunstone.health#question-311594","answers":[{"id":311609,"entity_id":"wefunder:comment:311609","answer":"$0.9034","author_name":"Joshua Resnikoff","votes":2,"created_at":"2025-07-20T12:52:45Z"},{"id":311614,"entity_id":"wefunder:comment:311614","answer":"Hi John, Thanks for your interest in TMA Precision Health. The current price of the Preferred Shares for our offering is $0.90342/share. The shares come with a 1x preference and an 8% accrued dividend. Please let us know if you have any further questions.","author_name":"Martin Grasso","votes":2,"created_at":"2025-07-20T17:24:43Z"}]},{"id":309876,"entity_id":"wefunder:comment:309876","question":"Questions will this be available for all level of health plans. If this is to scale into a \"go to help\" then it should be accessible to all levels of health plans in all insurance companies.","author_name":"Edmond Fernandez Jr","votes":6,"created_at":"2025-06-18T04:08:37Z","canonical_url":"https://wefunder.com/sunstone.health#question-309876","answers":[{"id":309892,"entity_id":"wefunder:comment:309892","answer":"Hi Edmond, thanks for the great question - 100% it works with, and will be available to, all levels of plans across all insurance companies. We're in conversation with the big guys (Blues etc) and already working with self-funded employer plans. Let me know if I can answer anything else? Thanks! Josh","author_name":"Joshua Resnikoff","votes":1,"created_at":"2025-06-18T15:55:48Z"}]},{"id":321738,"entity_id":"wefunder:comment:321738","question":"Is my initial investment still included?","author_name":"Frances Stout","votes":5,"created_at":"2025-12-23T18:47:13Z","canonical_url":"https://wefunder.com/sunstone.health#question-321738","answers":[{"id":321926,"entity_id":"wefunder:comment:321926","answer":"Yes, all investments that have been committed are included, thank you for your support!","author_name":"Joshua Resnikoff","votes":1,"created_at":"2025-12-28T16:36:03Z"}]},{"id":320843,"entity_id":"wefunder:comment:320843","question":"Hi Joshua, I'm invested in SEVERAL pre-IPO's!! So I'm going to be frank here!! My any only interest is any idea when you'll be going public so I can hopefully see some return on my investment....","author_name":"Vicky Rogers","votes":5,"created_at":"2025-12-09T17:01:33Z","canonical_url":"https://wefunder.com/sunstone.health#question-320843","answers":[{"id":320854,"entity_id":"wefunder:comment:320854","answer":"Hi Vicky, great question! Our more likely path is to exit via M\u0026amp;A in the next few years, based on similar companies in our space (and you should see the comps!). We work hard not to be just excellent stewards of capital, but aim to provide a great return - call it our professional experience in the space. I hope you will join us!!","author_name":"Joshua Resnikoff","votes":3,"created_at":"2025-12-09T17:51:53Z"}]},{"id":320705,"entity_id":"wefunder:comment:320705","question":"How much revenue will be booked at the end of 2025? And how many patients are signed up currently? And what’ll do you have a guaranteed revenue number for q1 of 2026 based off signed contracts?","author_name":"Eliezer SCHECHTER","votes":5,"created_at":"2025-12-07T02:14:56Z","canonical_url":"https://wefunder.com/sunstone.health#question-320705","answers":[{"id":320746,"entity_id":"wefunder:comment:320746","answer":"Hi Eliezer, thanks for your question. We're currently working with 10 patients and are in conversation with US employers in the 5,000+ member range, TPA's in the 100,000+ member range, and stop-loss insurance in the 1,000,000+ member range, aiming to get into the 1/1 start cycle. I would not put a \"guaranteed revenue\" number on the table for Q1 2026, but based on the above conversations I am extremely bullish about our prospects. Please let me know if I can answer anything else? Thanks! Josh","author_name":"Joshua Resnikoff","votes":0,"created_at":"2025-12-08T15:16:36Z"}]},{"id":317342,"entity_id":"wefunder:comment:317342","question":"Will you be extending this round?","author_name":"Jorinda Vide","votes":5,"created_at":"2025-10-17T19:55:56Z","canonical_url":"https://wefunder.com/sunstone.health#question-317342","answers":[{"id":317344,"entity_id":"wefunder:comment:317344","answer":"100% - should reopen at the end of the month! But you can commit today in advance. Thanks for your support!","author_name":"Joshua Resnikoff","votes":0,"created_at":"2025-10-17T20:01:22Z"}]},{"id":316553,"entity_id":"wefunder:comment:316553","question":"I WANT TO ADD $1000 TO MY EXISTING INVESMENT IN TMA Precision Health AND CAN'T FIND A WAY TO DO THAT.","author_name":"Harold Reynolds","votes":5,"created_at":"2025-10-08T12:59:47Z","canonical_url":"https://wefunder.com/sunstone.health#question-316553","answers":[{"id":316766,"entity_id":"wefunder:comment:316766","answer":"Thanks for your intent to invest more, Harold. We really appreciate your confidence! Just go to the TMA Campaign page and select the \"Learn\" menu in the upper right. From the drop down menu select \"Investor FAQ\". You will see a menu of choices on the left side from which you should choose \"Refunds and Reinvesting\". You should then see a list of \"How to\" instructions which include explicit instructions about how you can increase your investment, complete with examples. Please let me know if I can assist with anything else and thanks again for your commitment to our mission at TMA!","author_name":"Martin Grasso","votes":0,"created_at":"2025-10-10T20:12:51Z"}]},{"id":316015,"entity_id":"wefunder:comment:316015","question":"Can you explain what you guys do and the steps you go through after you identify a patient and sequence their genome up until you get paid for completing the case? Thanks","author_name":"Felix Vayssieres","votes":5,"created_at":"2025-09-30T18:24:16Z","canonical_url":"https://wefunder.com/sunstone.health#question-316015","answers":[{"id":316082,"entity_id":"wefunder:comment:316082","answer":"We will coordinate all of the diagnostics, genetic counseling, and medical review required to provide clinically specific doctor-to-doctor guidance that gets delivered back to the patient and their local care team for diagnosis and treatment implementation. We only charge employers when we deliver that package of information - so employers know that they are paying for a service that is being used by their members, not just a balloon subscription PEPM that has low utilization rates.","author_name":"Joshua Resnikoff","votes":0,"created_at":"2025-10-01T12:27:57Z"}]},{"id":315501,"entity_id":"wefunder:comment:315501","question":"Having invested in several pre-Ipos, I have experienced mostly the downside of the timeframes most ventures place on thier visions. One such example occurred on the Wefunder platform to build value by attracking donors. My surprise was when I spoke directly with the President of the venture. Their time frame was 7 years out! Despite having a viable product, making the Guiness Book of World Records for an autonomous dead weight lift by their design methodology, as wll as awarded a $48+M Federal DOD contract to use their product, they were determined to seek and vett all suitors. In the meantime, my investment is stagnant; 2) the sale is not guaranteed to come to fruition in seven years; 3) my control is limited at best, and 4) There is no qurantee they could go public, thus depriving me of potential lucrative gains in an IPO. Essentially, buyer beware.","author_name":"Douglas G Beaver","votes":5,"created_at":"2025-09-23T00:26:26Z","canonical_url":"https://wefunder.com/sunstone.health#question-315501","answers":[]},{"id":315476,"entity_id":"wefunder:comment:315476","question":"Wishing you (and me) much success! 🦄 🔥","author_name":"Yaakov Hersh","votes":5,"created_at":"2025-09-22T18:09:55Z","canonical_url":"https://wefunder.com/sunstone.health#question-315476","answers":[{"id":315481,"entity_id":"wefunder:comment:315481","answer":"Indeed, our interests are aligned. Thanks again for committing to our mission. We are laser focused on making this work for all of the stakeholders!","author_name":"Martin Grasso","votes":0,"created_at":"2025-09-22T18:49:15Z"}]},{"id":315473,"entity_id":"wefunder:comment:315473","question":"Hello (1) So you are hired by a company, look through their claims data for patients who might have a rare genetic disease, and sequence those patients' genomes to diagnosis their disease. Is that correct? If these diseases can be diagnosed with a genetic test why aren't doctors giving patients these tests already and why won't they start to give them themselves in the future without your intervention? (2) Since launching commercially how many patients have you tested? Thanks","author_name":"Felix Vayssieres","votes":5,"created_at":"2025-09-22T17:38:39Z","canonical_url":"https://wefunder.com/sunstone.health#question-315473","answers":[{"id":315579,"entity_id":"wefunder:comment:315579","answer":"Hi Felix -there are many challenges for these patients to get the test they need, including the length of time it takes them to get in front of a doctor that knows how to order the test and interpret the results, let alone the fact that most health insurance plans do not provide reimbursement for whole genome sequencing (and definitely not trio whole genome sequencing). Despite our best wishes, we are still a long time from genomics being part of the mainstream healthcare offerings when most major medical programs spend an average of 2 weeks teaching their new MDs how to think about genetics in their daily practice. Since launching commercially this spring in the US, we are now sequencing our first few dozen patients, with line of sight to hundreds in our customer funnel. Please let me know if you have any further questions, thanks! Josh","author_name":"Joshua Resnikoff","votes":0,"created_at":"2025-09-23T23:23:11Z"}]},{"id":315471,"entity_id":"wefunder:comment:315471","question":"Thank you for the quick response. What would your exit strategy look like? What time frame? Are we talking millions or billions🦄🔥🙂","author_name":"Yaakov Hersh","votes":5,"created_at":"2025-09-22T17:21:47Z","canonical_url":"https://wefunder.com/sunstone.health#question-315471","answers":[{"id":315475,"entity_id":"wefunder:comment:315475","answer":"While we try to avoid making forward looking statements, I would observe that the market comps and recent activity suggest that the most likely liquidity outcome would be an M\u0026amp;A event in the intermediate term. The total addressable market for companies like TMA that use AI and genomic medicine to create solutions that improve patient care and reduce cost are very large and robust. So we will be racing to scale our business in the near term to accrete value as quickly as possible. Many thanks again for your interest and confidence in our enterprise!","author_name":"Martin Grasso","votes":0,"created_at":"2025-09-22T17:47:17Z"}]},{"id":315433,"entity_id":"wefunder:comment:315433","question":"I need to know what bank account you have on file for me. There has been a change in my Chase account # recently. I will try to each you via phone to determine if any change to my prior info is needed. Harold Reynolds 230 382 1906 (also a new phone number)","author_name":"Harold Reynolds","votes":5,"created_at":"2025-09-21T16:30:26Z","canonical_url":"https://wefunder.com/sunstone.health#question-315433","answers":[{"id":315435,"entity_id":"wefunder:comment:315435","answer":"Hi Harold - I'm sorry but for security purposes we can't see that information. You might try reaching out to Wefunder customer service for help with any transactions, they manage that part. I am able to cancel your investment from my side of youd like?","author_name":"Joshua Resnikoff","votes":0,"created_at":"2025-09-21T16:47:49Z"}]},{"id":315128,"entity_id":"wefunder:comment:315128","question":"how can I increase my investment in TMA Precision?","author_name":"Steven A Ellers","votes":5,"created_at":"2025-09-17T22:31:49Z","canonical_url":"https://wefunder.com/sunstone.health#question-315128","answers":[{"id":315131,"entity_id":"wefunder:comment:315131","answer":"Thanks Steven! Instructions here To increase your investment on Wefunder after an initial investment has been finalized, you need to make a new, separate investment, which can be done by adding to the initial investment amount or creating a completely new investment. Be aware that if the round is oversubscribed, adding funds does not secure your spot in the queue, and your additional investment may not be accepted. Process to Increase Your Investment Go to your investment page: Log in to your Wefunder account and navigate to the \"My Portfolio\" or \"Investments\" section. Find TMA in your portfolio Create a new investment: Initiate a new investment with the additional amount you wish to invest. Follow the instructions: Complete the new investment process, which may include agreeing to terms and verifying your information. Appreciate the additional commitment!","author_name":"Joshua Resnikoff","votes":0,"created_at":"2025-09-17T23:02:04Z"}]},{"id":315049,"entity_id":"wefunder:comment:315049","question":"Circling back on QSBS status/question. I don't believe your answer is correct. As long as the company has under $75M of assets (which it certainly does if it's raising $5M @ a $8.5M pre-money valuation, it's clearly under the $75M limit. Many VCs that invest in early stage companies require that the companies they invest in qualify for QSBS, so having institutional investors in NO way hurts qualifying for the QSBS election. This is very important to investors, so would appreciate you digging into this a bit further. Here is some info for you relative to the diminimus test: Bigger Companies Now Qualify: $75M Gross Assets Test – QSBS is meant for small businesses, and the law uses a test based on the company’s assets to decide if it’s “small”. Previously, a corporation could not have aggregate gross assets exceeding $50 million at the time of (and immediately after) the stock issuance for it to count as QSBS. (“Aggregate gross assets” essentially means total assets, measured by cash plus the tax basis of other property – essentially the value of the company’s assets, not counting post-issuance growth.)This $50M threshold hadn’t changed since 1993, meaning in today’s world many “small” startups were bumping against it after a couple funding rounds. OBBBA increases the eligibility ceiling to $75 million in assets for stock issued after July 4, 2025. This is a significant expansion, allowing larger startups – or those with sizable funding – to still count as a “qualified small business.” For instance, a biotech company that raised $60M in venture capital would have blown the old limit, disqualifying its stock from QSBS; under the new $75M limit, investors in that round would still be eligible for QSBS on their shares. This change opens the door for later-stage investments and bigger scale-ups to offer QSBS benefits.","author_name":"Mike Mathioudakis","votes":5,"created_at":"2025-09-16T20:30:59Z","canonical_url":"https://wefunder.com/sunstone.health#question-315049","answers":[{"id":315109,"entity_id":"wefunder:comment:315109","answer":"Hi Mike, Thanks for following up with this valuable information. In the original response, we wanted to be careful (as the offeror) not to say anything that could be construed as individual accounting advice to non-accredited investors. However I think others who have invested or are considering investing can benefit from your research on this platform. So thanks for digging in and posting again, and most especially thanks again for having the confidence and conviction to invest in our mission It is greatly appreciated!","author_name":"Martin Grasso","votes":0,"created_at":"2025-09-17T18:57:06Z"}]},{"id":313666,"entity_id":"wefunder:comment:313666","question":"Hi, had a few questions if you can help with them.. Thanks. What makes your approach different from other precision health or genetic testing companies? How does the $10K case fee break down, and what’s your profit margin per case? How many health plan contracts are already signed? When will they start producing revenue? What market can you realistically reach in the next 2–3 years, and what are your growth targets? What protections (patents, trade secrets, partnerships) keep competitors from copying you? Can you share a patient or health-plan success story that shows your impact? What month do you expect to start generating revenue and what do you expect for 2025? What milestones should investors expect in the next 12–24 months, and how will they affect valuation?","author_name":"Yosef  Hertz","votes":5,"created_at":"2025-08-25T20:24:50Z","canonical_url":"https://wefunder.com/sunstone.health#question-313666","answers":[{"id":313671,"entity_id":"wefunder:comment:313671","answer":"Hi Yosef, thanks for the questions, I'll go through them one by one. We have two significant differentiators, the first being that our platform focuses on finding patients inside of employer claims data, effectively aggregating all patients that need our service upfront. The second being that we sell directly to employers, so we're not fighting reimbursement through commercial insurance. We are able to deploy our AI into claims data and then match the high cost patients to the appropriate resources to inform care guidance - what normally takes 7 years we can deliver in 12 weeks. We currently have a 60% gross margin and believe we can get to 80% with deeper automation. We have 4 contracts signed, revenue begins Q4 this year, anticipating $80k. We have just signed a paid 100 patient pilot starting this year ($1M rev, will be recognized in 2026) with a new customer with 11M lives, and we're exploring additional patient cohorts to service. There are stories in the details of our offer, but I can send you detailed examples identifying patients and generating savings if you like. Investors should expect us to scale significantly both across total numbers of patients lives touched and number of patients served, meaning we are growing both numerator and denominator for revenue generation - we've built the business to be revenue generating and not to be VC reliant for growth. My goal is to service 500 patients in 2026, and 2000 in 2027, achieving enterprise value of $100M+. Happy to connect directly from if I can provide more detail for you. Thanks! Josh","author_name":"Joshua Resnikoff","votes":0,"created_at":"2025-08-25T20:45:49Z"}]},{"id":312875,"entity_id":"wefunder:comment:312875","question":"What does your platform do better than or differently than Tempus AI, which has already gone public last year with a current $10B valuation and $200M quarterly revenue? Is it that you are targeting a different market than them? Or are you a direct competitor? Both your taglines are “Ai- Enabled Precision Medicine”, so I’m having trouble distinguishing the difference.","author_name":"Fred Hawkins III","votes":5,"created_at":"2025-08-09T13:45:36Z","canonical_url":"https://wefunder.com/sunstone.health#question-312875","answers":[{"id":312932,"entity_id":"wefunder:comment:312932","answer":"Tempus is a lab that powers testing once a doctor has already ordered it; TMA wins before that moment. We sell to self-funded employers, using claims-AI to surface hidden, high-cost genetic cases and more, then we orchestrate the right diagnostics and interventions through a lab-agnostic marketplace. That means we control who gets tested, where, and why—the lever that drives real cost reduction—while avoiding the capital intensity of running our own labs. Our model ties payment to measurable savings and outcomes (not PEPM), creating clear employer ROI and strong unit economics. In short: Tempus is a single point solution; TMA is the radar and air-traffic control that connects patients to the rights solutions. That upstream, cross-disease position gives TMA a large, under-served market, a capital-light path to scale, and asymmetric upside for investors.","author_name":"Joshua Resnikoff","votes":1,"created_at":"2025-08-11T14:42:27Z"}]},{"id":312654,"entity_id":"wefunder:comment:312654","question":"Hi there - I noticed that the entity that we are investing into was formed in 2024, and has no assets. Will all assets + IP be transferred to this new entity from its predecessor, TMAccelerator Company LLC, Management? And should I be evaluating this opportunity as if both TMAccelerator and this new TMA Inc. are one combined entity? Thank you.","author_name":"Teddy Lyons","votes":5,"created_at":"2025-08-07T14:04:08Z","canonical_url":"https://wefunder.com/sunstone.health#question-312654","answers":[{"id":312672,"entity_id":"wefunder:comment:312672","answer":"Hi Teddy, Yes your assumption is correct. TMAccelerator Company LLC will transfer all of its assets, including contracts, mission critical IP, etc to TMA, Inc. which is a clean shell that was set up to be the successor operating business dba TMA Precision Health. The LLC will continue to exist only as a holding company for the shares of the founders in order to protect their qualification as Small Business Stock under article 1202 of the IRS code. All of the docs for this transfer went through a rigorous review by an Independent CPA firm before Wefunder agreed to be the Listing Agent for the sale of the pref shares on the same terms as those offered and committed to by our lead institutional investor group. As of this time, we are planning on having a first close on committed capital when we reach $3MM in total b/w our Series A investors and the Wefunder investors. We are presently ~$55,000 below that goal. So we anticipate a closing sometime this month. Thanks for your interest and happy to answer any other questions you might have. Marty Grasso Co-founder and Chief Commercial Officer TMA Precision Health","author_name":"Martin Grasso","votes":0,"created_at":"2025-08-07T15:37:01Z"}]},{"id":309899,"entity_id":"wefunder:comment:309899","question":"Hey! Are you hiring app development team to build the app?","author_name":"Majed Mahmood","votes":5,"created_at":"2025-06-18T17:16:34Z","canonical_url":"https://wefunder.com/sunstone.health#question-309899","answers":[{"id":309902,"entity_id":"wefunder:comment:309902","answer":"Hi Majed, thanks for you question! Our app is already built! Our team is great. But I'm always open to learn about other service providers, please hmu on LinkedIn!","author_name":"Joshua Resnikoff","votes":0,"created_at":"2025-06-18T17:20:06Z"}]}],"faq":[{"question":"Your program sounds impressive and seems like a win-win-win for all involved. I have a few clarifying questions: The overview mentions a raise of $5M, but the top section lists a goal of $3.59M. Is there a discrepancy, or am I misinterpreting something? What is the exit strate...","answer":"Hi Alan and Leah - Thank you for your interest! We have worked extremely hard to make sure all parties win to drive adoption and scale. I have added additional clarifying information to the documentation and had Wefunder correct the displayed goal, apologies for the confusion. The full Series A round is for $5M. We have set aside $400,000 for our community to engage through Wefunder (with the remainder in discussion with other strategic and/or institutional investors). Our lead investor Satur..."},{"question":"hOW MUCH IS A SHARE WORTH NOW, TODAY?","answer":"$0.9034"},{"question":"I came across your Crowdfunding campaign on Wefunder and wanted to reach out. The Backer Hive is an invite-only club for serious backers interested in crowdfunding campaigns. With over 300k subscribers to our newsletter, we offer excellent rates to help promote your project th...","answer":"Thanks Saheed"},{"question":"I came across your Crowdfunding campaign on Wefunder and wanted to reach out. The Backer Hive is an invite-only club for serious backers interested in crowdfunding campaigns. With over 300k subscribers to our newsletter, we offer excellent rates to help promote your project th...","answer":"Thanks Saheed"},{"question":"I and interested, but have 2 quick questions. 1. Are we buying shares in this round, or it's simply pre-money SAFE which leads to per % of ownerships? 2. When was the company founded, and how much revenue so far?","answer":"Thanks for your interest Yubing! The company was founded at the end of 2019 and we spent a few years doing research and running a pilot out of Medellin Colombia. In 2023 we took the lessons and data we developed to reorganize as a scalable, software first platform, and starting actively selling to self-funded health plans in Q4 2024. We are currently pre-revenue, but have contracts that represent ~250,000 lives, and have a $2.3M revenue horizon for 2025. You are buying Series A preferred shar..."}]}}}